VCX

Across TCGA pan-cancer cohorts, VCX Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated VCX data layer compared with 18 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher VCX Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated VCX expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

SKCM are the cancer types where VCX Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	IV	1.000	0.201	.047	2	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

VCX–SKCM (DFS)

Open the SKCM breakdown →